NCT02971800View on ClinicalTrials.gov

Evaluation of Sodium Fluorescein Use During Intraoperative Cystoscopy After Total Laparoscopic Hysterectomy

NACompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

January 31, 2017

Study Completion Date

April 30, 2017

Conditions
Ureteral Injury
Interventions
DRUG

sodium fluorescein injection 10%

Trial Locations (1)

G1V 4G2

CHU de Québec, Québec

All Listed Sponsors
lead

CHU de Quebec-Universite Laval

OTHER

NCT02971800 - Evaluation of Sodium Fluorescein Use During Intraoperative Cystoscopy After Total Laparoscopic Hysterectomy | Biotech Hunter | Biotech Hunter